Pfizer’s Lyrica cleared for fibromyalgia

NEW YORK (AP) – Drug developer Pfizer Inc. said Thursday the Food and Drug Administration approved its drug Lyrica as a treatment for fibromyalgia, a widespread and chronic pain condition.

The drug is already approved as a diabetic nerve pain treatment. During the first quarter, Lyrica sales reached $395 million.

Pfizer said about 6 million Americans have fibromyalgia, which is characterized by chronic widespread pain and can cause poor sleep, stiffness and fatigue.

Shares of Pfizer rose 23 cents to close at $25.94.

————

Questions or comments about this story should be directed to Damian J. Troise at 212-621-7190

Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

  • bitcoinBitcoin (BTC) $ 111,694.00 0.58%
  • ethereumEthereum (ETH) $ 4,423.69 2.17%
  • xrpXRP (XRP) $ 2.85 0.29%
  • tetherTether (USDT) $ 1.00 0.04%
  • bnbBNB (BNB) $ 851.40 0.12%
  • solanaSolana (SOL) $ 208.48 1.03%
  • usd-coinUSDC (USDC) $ 0.999806 0.01%
  • staked-etherLido Staked Ether (STETH) $ 4,413.42 2.09%
  • tronTRON (TRX) $ 0.340473 0.61%
  • cardanoCardano (ADA) $ 0.827904 0.77%
  • avalanche-2Avalanche (AVAX) $ 25.23 3.48%
  • the-open-networkToncoin (TON) $ 3.19 0.5%
Enable Notifications OK No thanks